Uploading the document
“Q
4
2021 Memorandum for modeling purposes ”
Paris
(France)
–
the
4
January
202
2
– Sanofi announces the posting of a document entitled “Q4 2021 Memorandum for modeling purposes” on the Investors section of the company’s website.
https://www.sanofi.com/fr/investisseurs/resultats-et-evenements/resultats-financiers/resultats-Q4-2021
Like every quarter, this document aims to assist the financial community in modeling the Company’s quarterly results. This document contains a reminder of various non-recurring items and exclusivity losses, the effect of currency variations and the number of shares. Fourth quarter 2021 results will be announced on February 4, 2022.
About Sanofi
Sanofi’s vocation is to support those facing health problems. A global biopharmaceutical company specializing in human health, we prevent disease with our vaccines and offer innovative treatments. We support both those suffering from rare diseases and the millions of people suffering from a chronic disease.
Sanofi and its more than 100,000 employees in 100 countries transform scientific innovation into healthcare solutions around the world.
Media relations
Sandrine Guendoul
Phone: +33 (0) 6 25 09 14 2
[email protected]
Main Line Media Relations:
Phone: +33 (0) 1 53 77 46 46
[email protected]
Investor Relations
–
Paris
Eva Schaefer-Jansen
Arnaud Delépine
Nathalie Pham
Investor Relations – North America
Felix lauscher
Main Investor Relations Line:
Phone: +33 (0) 1 53 77 45 45
[email protected]
https://www.sanofi.com/en/investors/contact
Forward-looking statements
This press release contains forward-looking statements. These statements do not constitute historical facts. These statements include projections and estimates as well as the assumptions on which they are based, statements relating to plans, objectives, intentions and expectations regarding financial results, results,
Attachment
01-22-04 – Communique – FR